GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...

Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...

The medication, available at a lower cost, is an alternative to injections and increases accessibility for patients, some ...

Better Business Bureau president and CEO Randy Hutchinson gives insights on ways to avoid scams and protect assets.

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The ...

Getting your Trinity Audio player ready... Two men face multiple felony drug charges following searches of Adams County apartments and the seizure of what authorities said were an estimated 67,000 ...

Dr. Ashish Jha, Brown School of Public Health, joins 'Closing Bell Overtime' to talk Novo Nordisk getting approval fro a Wegovy pill, sending its stock climbing. Missing Kentucky teen found after two ...

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug. The Wegovy pill, as it’s called, is first oral version of a GLP-1 drug that ...

The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. Made by Novo Nordisk, the pill is taken once a day. The company’s original version of ...

The agency greenlit an oral version of the obesity drug Wegovy. By Dani Blum The Food and Drug Administration on Monday approved a pill version of the weight-loss injectable drug Wegovy, offering ...

Experts say a promising sleep apnea pill may soon transform how millions manage the condition, pending FDA approval. Putin derides European leaders as he insists Russia's war goals in Ukraine will be ...